A deep learning based holistic diagnosis system for immunohistochemistry interpretation and molecular subtyping
Background: Breast cancer in different molecular subtypes, which is determined by the overexpression rates of human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), progesterone receptor (PR), and Ki67, exhibit distinct symptom characteristics and sensitivity to different treatment...
Main Authors: | Lin Fan, Jiahe Liu, Baoyang Ju, Doudou Lou, Yushen Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558624000137 |
Similar Items
-
The Prognostic Impact of Age at Diagnosis Upon Breast Cancer of Different Immunohistochemical Subtypes: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Analysis
by: Shibin Cai, et al.
Published: (2020-09-01) -
Immunohistochemical subtypes of the breast cancer in the ultrasound and clinical aspect – literature review
by: Dobruch-Sobczak Katarzyna, et al.
Published: (2022-04-01) -
A Clinicopathological Analysis of Molecular Subtypes of Breast Cancer using Immunohistochemical Surrogates: A 6-Year Institutional Experience from a Tertiary Cancer Center in North India
by: Puneet Kaur Somal, et al.
Published: (2023-04-01) -
Using immunohistochemistry to classify the molecular subtypes of Paget's disease of the breast
by: Yujiao Cai, et al.
Published: (2023-07-01) -
Implantable Microimagers
by: Jun Ohta, et al.
Published: (2008-05-01)